Population
In vitro model using myosin subfragment 1 (S1) and actoS1
Comparison
Methylated 2-[amino]ethyl triphosphate vs Non-methylated dNOTP and ATP
Design
Preclinical
Authors
Loading...
Methylation disrupts myosin nucleotide binding in vitro; leaves open whether adenine modifications can guide cardiac myosin modulator development.
Methylation of dNOTP prevents specific interaction with myosin S1 in the adenine binding region, abolishing its ability to support actin sliding and providing insights into actomyosin chemomechanical transduction.
Gopal et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: